In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acorn closes $20mm Series E round

Executive Summary

Acorn Cardiovascular (develops medical devices for heart failure) raised $20mm in a private placement of Series E preferred stock. Johnson & Johnson Development Corp. led the financing and was joined by return investors New Enterprise Associates, CSFB, Piper Jaffray Ventures, Three Arch Partners, Bessemer Venture Partners, Spray Venture Fund, and others.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies